Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

AstraZeneca Wants Expanded Use Of Seroquel

Posted by Jane Akre
Wednesday, December 24, 2008 11:30 AM EST
Category: Major Medical, Protecting Your Family
Tags: Seroquel, AstraZeneca, FDA and Prescription Drugs, Bipolar Disorder, Schizophrenia, Depression, Dangerous Drugs, Diabetes

AstraZeneca wants to use seroquel for depression.


IMAGE SOURCE: Wikimedia Commons/ Seroquel pills/ author: Lucas Bombach


AstraZeneca’s Seroquel is already approved by the U.S. Food and Drug Administration (FDA) to be used by people suffering from schizophrenia or the severe mood swings of bipolar disorder.

Now AstraZeneca PLC wants to expand the use of Seroquel and has applied to the FDA for use of Seroquel as a treatment for depression in adults.  In response, the FDA has asked AstraZeneca for more information, in the form of a complete response letter (CRL). 

Seroquel XR is one of the London-based company’s best-selling drugs next to heartburn drug, Nexium. It reportedly raked in $4 billion in sales last year, according to the Associated Press

"AstraZeneca is evaluating the contents of the CRL and the proposed labeling revisions," the company said in a statement to the London Stock Exchange."AstraZeneca will continue discussions with the FDA and will provide a response to the agency in due course."

In October, Seroquel received FDA approval for its extended-release version to be used to treat bipolar disorder, making Seroquel XR (“XR” indicates extended release), the first medication cleared for depressive and manic episodes associated with bipolar disorder.  It was approved as a once-daily treatment. The previous version was taken twice a day and not approved for mixed episodes.

Recreating the drug with an XR means that the patent is protected until 2017.  The original formula was set to expire in 2011. Patients will be switched into the XR version. 

Seroquel (Quetiapine Fumarate) was approved by the FDA in 1997. 

Earlier this year, Bloomberg reported that teenagers and the elderly were increasingly being given a class of anti-psychotic drugs not cleared by regulators, among them Seroquel and Zyprexa, which had driven growth for both pharmaceutical companies.  In adolescents, the medications are given for depression, autism and hyperactivity, and in the elderly for dementia and insomnia. 

Half of Seroquel’s sales in 2006 were reportedly for off-label use.  

In September 2003, the FDA recommended that six atypical antipsychotics, including Seroquel, carry a diabetes warning because Seroquel patients were three times more likely to develop diabetes than those taking older drugs.

The most common side effects of Seroquel use include, but may not be limited to, drowsiness, weight gain, restlessness, dizziness, increased appetite, constipation and fatigue

Antipsychotic drugs such as Seroquel have been linked to two serious complications known as Neuroleptic Malignant Syndrome (NMS) and Tardive Dyskinesia.

NMS is a potentially fatal syndrome involving muscle rigidity, an altered mental state and symptoms of cardiac instability (irregular blood pressure, tachycardia, irregular pulse).

Tardive Dyskinesia is a central nervous system disorder characterized by involuntary movements of the limbs as well as twitching of the face and tongue.  #

1 Comment

Anonymous User
Posted by Jeff O'Shields
Friday, December 26, 2008 6:49 PM EST

Refuse to allow your loved one (esp. one who suffers from Alzheimer's) to be prescribed ANY neuroleptic medications! I watched my mother suffer from all of the above-described symptoms then found out that she had been prescribed Seroquel, Zyprexa and Haldol.

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact an Injury Board member

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address


RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes